What does S and OP look like when the forecast unit is one patient's prescription, not a SKU[1]? When 503A work is patient specific[2], 503B work is office use and regulated as cGMP[2], USP 795 default BUDs cap aqueous preparations at 35 days preserved and stability extensions at 180 days[6], FDA pulled injectable semaglutide off the shortage list in February 2025 and whipsawed compounder demand within weeks[3], and 20 percent of US API sits at 467 China registered sites with 21 percent more from India under routine Import Alert 66-40 scrutiny[8]? Caddie, Enmovil's agentic AI, sits above your ERP, your PIMS, your compounding lab schedule, and Blue Rabbit[16]. Closes the loop from API shipment to the patient's refill, with demand planning built for intermittent demand[15].
Wedgewood operates five PCAB accredited state licensed pharmacies and two FDA registered cGMP 503B outsourcing facilities. A 46,000 plus formulary. More than 50,000 prescribing veterinarians. 70,000 plus clinics. Over one million animals served a year[1]. The US compounding pharmacy market sits at roughly 6.45 billion dollars in 2025 and 6.82 billion dollars in 2026[4]. Animal drug compounding alone is 1.68 billion dollars in 2025 and tracks toward 3.25 billion dollars by 2033[5]. The FDA removed injectable semaglutide from the shortage list on February 21, 2025. 503A compounders had until April 22, 2025 and 503B until May 22, 2025 to cease copies[3]. The China India API base is 20 percent plus 21 percent of US supply, with Import Alert 66-40 routinely detaining shipments on data integrity grounds[8]. Chandler AZ opened a 90,000 square foot facility in 2025 with 250 jobs planned by 2027[7]. NJMEP value stream mapping in 2024 targeted a 30 percent production time reduction[11]. So what does S and OP look like when most SKUs ship rarely, a few ship daily, and the forecast is really a lot size of one distribution?
A demand signal enters at Demand Sensing. It exits at Settlement. Autonomously. In minutes. Then the next one enters. The loop runs 24/7.[16]
Every number below comes from deployed customer outcomes on the Enmovil platform. Not projections. We show you the deployments. You pick the one closest to Wedgewood's shape.
What we are not promising on this page: a specific BUD writedown delta, a forecast accuracy number, or a fiscal year figure. Those are the things we think are true. We want to scope them with you in the room, not pre print them on a slide.
We do not have a US compounding pharmacy to name yet. We have a high SKU, low velocity aftermarket network, an FMCG raw material plus finished goods integrated plan, and a Fortune 500 SAP native manufacturer where the operating shape is close enough that the pattern transfers. Named references available under NDA at the booth.
One AI-native platform. Demand sensing, inventory, dispatch, execution, freight settlement, sustainability reporting. All on one intelligence layer that sits above the systems you already own.







A thirty minute working session. Not a demo. We leave the room with three scoped experiments and a shared view of where next fiscal's operating margin actually sits, post restructuring. Three questions we want to ask before the session. Your answers tell us what experiments to bring.
If you have already solved these, that is the conversation we most want to have. Harry is the spine. Bring one demand planner and one production planner on each coast, and one API buyer.